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Background. Harmful uremic toxins, such as indoxyl sulfate
(IS), 3-carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF),
indoleacetate (IA), and hippurate (HA), accumulate to a high
degree in uremic plasma. IS has been shown to be a substrate of
rat organic anion transporter 1 (rOat1) and rOat3. However, the
contribution of rOat1 and rOat3 to the renal uptake transport
process of IS and other uremic toxins in the kidney remains
unknown.
Methods. The cellular uptake of uremic toxins was deter-
mined using stable transfectants of rOat1/hOAT1 and rOat3/
hOAT3 cells. Also, the uptake of uremic toxins by rat kidney
slices was characterized to evaluate the contribution of rOat1
and rOat3 to the total uptake by kidney slices using inhibitors
of rOat1 (p-aminohippurate) and rOat3 (pravastatin and ben-
zylpenicillin).
Results. Saturable uptake of IS, CMPF, IA, and HA by rOat1
was observed with Km values of 18, 154, 47, and 28 lmol/L, re-
spectively, whereas significant uptake of IS and CMPF, but not
of IA or HA, was observed in rOat3-expressing cells with Km
values of 174 and 11 lmol/L, respectively. Similar parameters
were obtained for human OAT1 and OAT3. Kinetic analysis of
the IS uptake by kidney slices revealed involvement of two sat-
urable components with Km1 (24 lmol/L) and Km2 (196 lmol/L)
values that were comparable with those of rOat1 and rOat3. The
Km value of CMPF uptake by kidney slices (22 lmol/L) was
comparable with that of rOat3, while the corresponding values
of IA and HA (42 and 33 lmol/L, respectively) were similar to
those of rOat1. PAH preferentially inhibited the uptake of IA
and HA by kidney slices, while pravastatin and benzylpenicillin
preferentially inhibited the uptake of CMPF. The effect of these
inhibitors on the uptake of IS by kidney slices was partial.
Conclusion. rOat1/hOAT1 and rOat3/hOAT3 play major
roles in the renal uptake of uremic toxins on the basolateral
membrane of the proximal tubules. Both OAT1 and OAT3 con-
tribute almost equally to the renal uptake of IS. OAT3 mainly
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accounts for CMPF uptake by the kidney, while OAT1 mainly
accounts for IA and HA uptake.
Uremic syndrome is a complex form of organ dys-
function, which causes the retention of waste prod-
ucts that, under normal condition, should be eliminated
from the body by the kidneys [1]. Organic anions, such
as indoxyl sulfate (IS), 3-carboxy-4-methyl-5-propyl-2-
furanpropionate (CMPF), indoleacetate (IA) and hip-
purate (HA), derived from dietary protein, are mainly
excreted into the urine, but they accumulate to a high de-
gree in uremic plasma [2]. These organic anions have been
proposed to cause uremic syndrome, including defective
protein binding of drugs, irregularities in thyroid func-
tion, inhibition of active tubular secretion, neurologic
symptoms, inhibition of drug metabolism in the liver,
and stimulation of ammoniagenesis [3, 4]. Thus, these
compounds have been referred to as “uremic toxins.”
In particular, it has been proposed that the increased
serum level of uremic toxins including IS may accel-
erate the deterioration of renal function in chronic re-
nal failure [5]. In fact, administration of AST-120, an
oral absorbent, decreased the serum and urinary con-
centrations of IS and prevented the progression of renal
dysfunction by reducing the gene expression, such as
transforming growth factor-b1 (TGF-b1), tissue inhibitor
of metalloproteinase-1 (TIMP-1), and pro-a1(I) colla-
gen, in the kidney [6].
In renal tubules, membrane transport systems medi-
ate the tubular secretion of endogenous and exogenous
organic anions, such as various drugs, toxins, and endoge-
nous metabolites. Rat organic anion transporter 1 (rOat1;
Slc22a6), of which p-aminohippurate (PAH) is a typi-
cal substrate, was isolated from rat kidney as the classic
renal organic anion transporter [7]. rOat1 is expressed
predominantly in the kidney and is localized on the ba-
solateral membrane of the middle proximal tubules (S2)
[8]. rOat1 has broad substrate specificity and accepts a
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variety of drugs, such as nonsteroidal anti-inflammatory
agents, b-lactam antibiotics, methotrexate, and antiviral
drugs and various endogenous organic anions, such as
cyclic nucleotides, prostaglandins, dicarboxylates, and fo-
late [9]. Subsequently, two isoforms, referred to as rOat2
(Slc22a7) and rOat3 (Slc22a8), were identified in rats [10,
11]. Northern blot analyses indicated that rOat2 is ex-
pressed abundantly in the liver and female kidney but
only weakly in the male kidney [10, 12], while rOat3 is ex-
pressed in the male liver, kidney, brain, and only weakly
in the eye [11]. rOat3 in the kidney is located on the ba-
solateral membrane in all the segments (S1, S2, and S3)
of the proximal tubules [13, 14]. Functional characteriza-
tion shows that substrates of rOat3 include organic an-
ions, such as estrone sulfate, pravastatin, benzylpenicillin
(PCG), 17b-estradiol-D-17b-glucuronide, ochratoxin A,
PAH, and an organic cation, cimetidine [11, 14, 15].
The contribution of rOat1 and rOat3 to the renal up-
take of organic anions has been evaluated in kidney
slices, and it has been proposed that rOat1 is mainly re-
sponsible for the renal uptake of hydrophilic and small
molecules, while rOat3 is responsible for the renal up-
take of more bulky organic anions [14, 16]. Human OAT1
(hOAT1) and human OAT3 (hOAT3) are also predomi-
nantly expressed in the kidney and are coexpressed on
the basolateral membrane in some part of the proxi-
mal tubules [17–19]. Based on transport studies in rats,
it has been considered that hOAT1 and hOAT3 play
a predominant role in the transport of organic anions
across the basolateral membrane of human proximal
tubules.
IS, CMPF, and HA produce significant inhibition of
PAH transport in the kidney [2, 20, 21], suggesting that
these compounds are transported by the organic an-
ion transport system. Previous transport studies using
expression systems have revealed that both rOat1 and
rOat3 accept IS as a substrate [22, 23]. hOAT1 accepts
IS and IA as a substrate [24], and IS is a substrate
of hOAT3 and hOAT4 [25]. CMPF and HA have in-
hibitory effects on the renal uptake of IS in the in vivo
tissue-sampling single-injection technique [i.e. the kidney
uptake index (KUI) method] [22]. Moreover, HA sig-
nificantly inhibited PAH transport by hOAT1-expressing
cells [24]. Therefore, these uremic toxins have been sug-
gested to be substrates of rOats/hOATs [2, 22, 24]. How-
ever, limited information is available concerning the con-
tribution by rOat1 and rOat3 to the total renal uptake of
uremic toxins in the kidney. It is important to identify the
organic anion transporter responsible for the renal up-
take of uremic toxins because inhibition or malfunction
of the organic anion transporter will cause their serum
accumulation. Furthermore, accumulation of uremic tox-
ins in the circulating blood may lead to inhibition of the
membrane transport of other exogenous and endogenous
organic anions.
The purpose of the present study was to investigate
the contribution of rOat1 and rOat3 to the renal up-
take of uremic toxins (IS, CMPF, IA, and HA). Trans-
port studies using cDNA-transfected cells revealed that
rOat1/hOAT1 accepts all uremic toxins examined in this
study as substrates, while rOat3/hOAT3 accepts only IS
and CMPF. The uptake of uremic toxins was determined
in kidney slices, and the effect of inhibitors relatively se-
lective for rOat1 and rOat3 for their uptake was exam-
ined. Furthermore, kinetic parameters were compared
between rat and human rOats/hOATs.
METHODS
Materials
CMPF was synthesized as previously described [26].
[3H]IS (6.5 Ci/mmol) and [3H]CMPF were synthesized
and purified by Perkin Elmer Life Sciences (Boston,
MA, USA). [3H]IA (26.0 Ci/mmol) and [3H]PCG (19.0
Ci/mmol) were obtained from Amersham Pharma-
cia Biotech (Little Chalfont, Buckinghamshire, UK).
[14C]HA (55 mCi/mmol) was purchased from American
Radiolabeled Chemicals (St. Louis, MO, USA). [3H]PAH
(4.08 Ci/mmol) and [14C]mannitol (51 mCi/mmol) were
purchased from Perkin Elmer Life Sciences. Unlabeled
IS, IA, and PAH were purchased from Sigma, and un-
labeled HA, PCG, dibromosulfophthalein (DBSP) from
Wako Pure Chemical Industries (Osaka, Japan). Unla-
beled pravastatin was kindly donated by Sankyo (Tokyo,
Japan). All other chemicals were of analytical grade and
commercially available.
Cell culture
rOat1- and rOat3-expressing pig kidney epithelial cell
line (LLC-PK1) cells were established as we described
previously [15]. LLC-PK1 cells were grown on the bot-
tom of a dish in M199 (Medium 199; Invitrogen, Carlsbad,
CA, USA) supplemented with 10% fetal bovine serum,
penicillin (100 U/mL), streptomycin (100 lg/mL), and
G418 (400 lg/mL) (Geneticin; Invitrogen) at 37◦C with
5% CO2 and 95% humidity.
Stable transfectants of hOAT1 and hOAT3 were es-
tablished using HEK293 cells as host. Briefly, full-length
hOAT1 [17] was subcloned into the pcDNA3.1 vector
(Invitrogen) and full-length hOAT3 [18] was subcloned
into the pIRES2-EGFP vector (Clontech, Palo Alto, CA,
USA). This construct of hOAT1 was introduced into
HEK293 cells by lipofection with FuGENE 6 (Roche
Diagnostics, Basel, Switzerland), and that of hOAT3
was introduced into HEK293 cells by lipofection with
LipofectAMINE (Invitrogen) according to the manu-
facturer’s protocols, and stable transfected cells were
selected by adding G418 to the culture medium. Two
weeks after transfection, positive clones were selected
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by their transport activity for typical substrates (PAH for
hOAT1[17]; estrone sulfate and PCG for hOAT3 [18]).
HEK293 cells were grown on the bottom of a dish in
Dulbecco’s modified Eagle’s medium (Invitrogen) sup-
plemented with 10% fetal bovine serum, penicillin (100
U/mL), streptomycin (100 lg/mL), and G418 (400 lg/mL)
at 37◦C with 5% CO2 and 95% humidity.
Cells were seeded in 12-well plates at a density of
1.2 × 105 cells/well and cultured for 3 days. Cell cul-
ture medium was replaced with culture medium sup-
plemented with sodium-butyrate (5 mmol/L) 24 hours
before transport studies to induce the expression of rOats
and hOATs.
Transport studies
Transport studies were carried out as described pre-
viously [15]. The transport activity of rOat1 and rOat3
was assessed using the cells cultured in the dish. The up-
take from the basal and apical sides was almost equal
when the cells were cultured on porous membrane, sug-
gesting that a similar amount of transporter protein is
expressed on the apical and basal membranes of each
cDNA-transfected LLC-PK1 cell [15]. Uptake was ini-
tiated by adding medium containing radiolabeled com-
pounds after cells had been washed twice and preincu-
bated with Krebs-Henseleit buffer at 37◦C for 15 minutes.
The Krebs-Henseleit buffer consists of 118 mmol/L NaCl,
4.83 mmol/L KCl, 0.96 mmol/L KH2PO4, 1.20 mmol/L
MgSO4, 1.53 mmolL CaCl2, 12.5 mmol/L HEPES, 23.8
mmol/L NaHCO3, 5 mmol/L glucose, and adjusted to pH
7.4. The uptake was terminated at a designated time by
adding ice-cold Krebs-Henseleit buffer after removal of
the incubation buffer. Then, cells were washed twice with
1 mL ice cold Krebs-Henseleit buffer, dissolved in 500 lL
of 0.2 N NaOH, and kept overnight. Aliquots (450 lL)
were transferred to scintillation vials after adding 100 lL
of 1 N HCl. The radioactivity associated with the cells and
medium specimens was determined by liquid scintilla-
tion counting after adding scintillation fluid (NACALAI
TESQUE, Kyoto, Japan) to the scintillation vials. The re-
maining 50 lL of the aliquots of cell lysate were used to
determine the protein concentration by the method of
Lowry with bovine serum albumin as a standard.
Ligand uptake is given as the cell-to-medium concen-
tration ratio determined as the amount of ligand associ-
ated with the cells divided by the medium concentration.
Specific uptake was obtained by subtracting the uptake
into vector-transfected cells from the uptake into cDNA-
transfected cells. Kinetic parameters were obtained using
the following equation (Michaelis-Menten equation):
One saturable component,
v = Vmax × S
Km + S (1)
One saturable (two saturable) and one nonsaturable
component,
v = Vmax1 × S
Km1 + S +
(
Vmax 2 × S
Km2 + S
)
+ CLnon × S (2)
where v is the uptake velocity of the substrate
(pmol/min/mg protein), S is the substrate concentration
in the medium (lmol/L), Km is the Michaelis-Menten
constant (lmol/L), Vmax is the maximum uptake rate
(pmol/min/mg protein), and CLnon is the nonsaturable
uptake clearance. The number of components involved
in the uptake by cDNA-transfected cells or kidney slices
was determined based on Akaike’s Information Criterion
(AIC) values [27]. Inhibition constants (Ki values) of a
series of compounds were obtained by examining their in-
hibitory effects on the rOat1/hOAT1- and rOat3/hOAT3-
mediated uptake assuming competitive inhibition under
the condition that the substrate concentration was much
lower than its Km value using the following equation:
CL+I = CL1 + Ki (3)
where CL represents the uptake clearance and the sub-
script (+I) represents the value in the presence of
inhibitor. I represents the concentration of inhibitor
(lmol/L). The substrate concentration was low compared
with its Km value in the inhibition study. Fitting was per-
formed by the nonlinear least-squares method using a
MULTI program [27] and the Damping Gauss Newton
Method algorithm.
Uptake by kidney slices
Uptake studies were carried out as described in a
previous report [14]. Slices (0.3 mm thick) of whole
kidneys from male Sprague-Dawley rats were put in
ice-cold oxygenated incubation buffer. The incubation
buffer consisted of 120 mmol/L NaCl, 16.2 mmol/L KCl,
1 mmol/L CaCl2, 1.2 mmol/L MgSO4, and 10 mmol/L
NaH2PO4/Na2HPO4 adjusted to pH 7.5. Two slices, each
weighing 10 to 20 mg, were randomly selected and then
incubated in a 12-well plate with 1 mL oxygenated incuba-
tion buffer in each well after slices had been preincubated
with incubation buffer for 5 minutes. The uptake study
of 1 lmol/L radiolabeled compounds was carried out at
37◦C. [14C]Mannitol (1 lmol/L) was used to estimate the
water adhering to the kidney slices in each experiment.
After incubating for an appropriate time, each slice was
rapidly removed from the incubation buffer, washed in
ice-cold saline, blotted on filter paper, weighed, and dis-
solved in 1 mL of soluene-350 (Perkin Elmer Life Sci-
ences) at 50◦C for 3 hours. The radioactivity was deter-
mined in a liquid scintillation counter after adding 10 mL
of scintillation fluid (Perkin Elmer Life Sciences).
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Ligand uptake was given as the amount of ligand as-
sociated with the slice specimens divided by the medium
concentration. The Km and Ki values were obtained using
equations as described previously.
Estimation of uptake clearance in kidney slices
from cDNA-transfected cells
Using the Relative Activity Factor (RAF) concept, we
estimated the contribution of rOat1 and rOat3 to the to-
tal uptake by kidney slices [16, 28]. A scaling factor for
rOat1- and rOat3-mediated transport was obtained us-
ing PAH and PCG as reference compounds. The uptake
clearances of uremic toxins by cDNA-transfected cells
(CLrOat1 and CLrOat3) multiplied by RrOat1 and RrOat3, re-
spectively, are summarized in Table 3.
RrOat1 = CLPAH,sliceCLPAH,rOat1 (4)
RrOat3 = CLPCG,sliceCLPCG,rOat3 (5)
CLtest,slice = CLtest,rOat1 · RrOat1 + CLtest,rOat3 · RrOat3 (6)
RESULTS
Uptake of uremic toxins by rOat1- and
rOat3-expressing LLC-PK1 cells
The activity of rOat1- and rOat3-expressing LLC-PK1
cells was confirmed in each study by the transport of PAH
(1 lmol/L) and PCG (1 lmol/L), respectively. The mean
activities of rOat1- and rOat3-expressing LLC-PK1 cells
were 20.1 ± 1.2 and 2.75 ± 0.59 lL/min/mg protein, re-
spectively, and these values are comparable to those in a
previous report [29].
The time profiles of the uptake of IS, CMPF, IA,
and HA by rOat1- and rOat3-expressing, and vector-
transfected LLC-PK1 cells are shown in Figure 1. The
intracellular accumulation of IS, CMPF, IA, and HA was
significantly greater in rOat1-expressing LLC-PK1 cells
than in vector-transfected cells. On the other hand, a sig-
nificant increase in the uptake of IS and CMPF was ob-
served in rOat3-expressing LLC-PK1 cells, but not IA
and HA.
The concentration-dependence of the uptake of ure-
mic toxins by rOat1 and rOat3 was investigated (Fig. 2)
and kinetic parameters for their uptake are summarized
in Table 1. IS had a 10-fold greater Km value for rOat3
than rOat1. Conversely, CMPF had a 15-fold greater Km
value for rOat1 than rOat3. The transport activities of IS
and HA by rOat1 were similar, and these values were ap-
proximately 2-fold greater than those of CMPF and IA
in rOat1-expressing cells. The transport activity of IS and
CMPF by rOat3 was comparable (Table 1).
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Fig. 1. Time profiles of the uptake of uremic toxins by rat organic anion
transporter (rOat)1- and rOat3-expressing pig kidney epithelial cell line
(LLC-PK1) cells. (A) The uptake of 1 lmol/L [3H]IS, (B) 1 lmol/L
[3H]CMPF, (C) 1 lmol/L [3H]IA, and (D) 1 lmol/L [14C]HA by cDNA-
transfected cells was examined at 37◦C. Squares, closed circles, and
triangles represent the uptake by rOat1- and rOat3-expressing cells and
vector-transfected LLC-PK1cells, respectively. Each point represents
the mean ± SE (N = 3). Abbreviations are: IS, indoxyl sulfate; CMPF, 3-
carboxy-4-methyl-5-propyl-2-furanpropionate; IA, indoleacetate; HA,
hippurate.
The inhibitory effect of uremic toxins on the uptake via
rOat1 and rOat3 is shown in Figure 3. The Ki values ob-
tained assuming competitive inhibition are summarized
in Table 2. The Ki value of IS for rOat1 was smaller than
that for rOat3, and the Ki value of CMPF for rOat3 was
smaller than that for rOat1. These results agreed with the
results obtained by the Eadie-Hofstee plots as shown in
Table 1. The Ki values of IA and HA were determined
for the uptake of PCG by rOat3, because no significant
uptake of IA and HA was observed in rOat3-transfected
cells. HA inhibited the transport by rOat3 with a Ki value
similar to the Km and Ki values for rOat1. IA inhibited
the transport via rOat3, but the Ki value for rOat3 was
much greater than that for rOat1.
Uptake of uremic toxins by kidney slices
The activity of kidney slices was confirmed in each
study by the uptake of PAH (1 lmol/L) and PCG
(1 lmol/L). The mean uptake clearance of PAH and PCG
was 0.276 ± 0.018 and 0.200 ± 0.004 mL/min/g of kidney,
respectively.
The time profiles and the concentration-dependence
of the uptake of uremic toxins by rat kidney slices are
shown in Figure 4. The Km and Vmax values obtained by
kinetic analysis are summarized in Table 1. Analysis of the
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Fig. 2. Eadie-Hofstee plots of the uptake of uremic toxins by rat organic anion transporter (rOat)1- and rOat3-expressing pig kidney epithelial
cell line (LLC-PK1) cells. (A and E) The concentration dependence of [3H]IS, (B and F) [3H]CMPF, (C) [3H]IA, and (D) [14C]HA by cDNA-
transfected cells is shown. Squares and closed circles represent the uptake by rOat1- and rOat3-expressing cells, respectively. The uptake by rOat1-
and rOat3-expressing cells was measured for 1 minute and 2 minutes at various concentrations (IS, CMPF, and IA, 0.3–1000 lmol/L, HA, 2–1000
lmol/L). The rOat1- and rOat3-mediated transports were obtained by subtracting the transport velocity in vector-transfected cells from those in
rOat1- and rOat3-expressing cells. Each point represents the mean ± SE (N = 3). Abbreviations are: IS, indoxyl sulfate; CMPF, 3-carboxy-4-methyl-
5-propyl-2-furanpropionate; IA, indoleacetate; HA, hippurate.
Table 1. Kinetic parameters of the uptake of uremic toxins PAH and PCG by rOat1-, rOat3-expressing LLC-PK1 cells, and kidney slices
rOat1-LLC-PK1 rOat3-LLC-PK1 Kidney slice
Vmax Vmax/Km Vmax Vmax/Km Vmax Vmax/Km
Km pmol/min/mg lL/min/mg Km pmol/min/mg lL/min/mg Km nmol/min/g mL/min/g
lmol/L of protein of protein lmol/L of protein of protein lmol/L of kidney of kidney
IS 17.7 ± 5.3 350 ± 80 19.7 174 ± 24 1047 ± 115 6.02 24.1 ± 11.1 1.48 ± 1.16 0.061
(3.42 ± 0.39) 19.6 ± 44 19.6 ± 1.2 0.100
(0.039 ± 0.001)
CMPF 154 ± 14 1669 ± 114 10.8 10.9 ± 2.0 66.4 ± 9.2 6.09 22.4 ± 7.0 5.40 ± 1.45 0.241
(0.33 ± 0.04) (0.068 ± 0.007)
IA 47.1 ± 17.3 387 ± 131 8.22 – – – 41.5 ± 6.5 8.08 ± 1.18 0.195
(1.39 ± 0.30) (0.076 ± 0.004)
HA 27.5 ± 4.7 519 ± 69 18.9 – – – 33.0 ± 3.2 8.96 ± 0.67 0.272
(0.92 ± 0.15) (0.015 ± 0.001)
PAH – – 20.1 – – – – – 0.276
PCG – – – – – 2.75 – – 0.200
Abbreviations are: rOat, rat organic anion transporter, LLC-PK1, pig kidney epithelial cell line; PAH, p-aminohippurate; PCG, benzyl-penicillin; IS, indoxyl sulfate;
IA, indoleacetate; HA, hippurate; CMPF, 3-carboxy-4-methyl-5-propyl-2-furanpropionate.
Data shown in Figures 2 and 4 were used to determine the kinetic parameters for the uptake of organic anions by cDNA-transfected cells and kidney slices. CLnon
values are given in parentheses. These parameters were determined by nonlinear regression analysis. Reproducibility of the transport activities by cDNA-transfected
cells and kidney slices (Vmax/Km) was confirmed by 4-10 individual experiments. In every experiment, PAH and PCG were used as reference compounds to check the
transport activity by cDNA-transfected cells and kidney slices. Each value represents the mean ± SD (N = 3).
uptake of IS by kidney slices revealed two saturable and
one nonsaturable components (Km1 and Vmax1 = 24.1 ±
11.2 lmol/L and 1.48 ± 1.16 nmol/min/g of kidney; Km2
and Vmax2 = 196 ± 44 lmol/L and 19.6 ± 1.2 nmol/min/g
of kidney; CLnon = 0.039 ± 0.001 mL/min/g of kidney),
although only one saturable and one nonsaturable com-
ponent were observed in the uptake of CMPF, IA, and
HA (Fig. 4).
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Fig. 3. Inhibitory effect of uremic toxins on the uptake of [3H]PAH
and [3H]PCG by rat organic anion transporter (rOat)1- and rOat3-
expressing pig kidney epithelial cell line (LLC-PK1) cells. rOat1-
mediated 1 lmol/L [3H]PAH uptake for 1 minute and rOat3-mediated
1 lmol/L [3H]PCG uptake for 2 minutes were determined in the pres-
ence and absence of unlabeled IS (), CMPF (©), IA (), and HA
() at the designated concentrations. The values are expressed as a per-
centage of the uptake in the absence of any unlabeled compounds. Solid
lines represent the fitted line obtained by nonlinear regression analysis.
Each point represents the mean ± SE (N = 3). Abbreviations are: IS, in-
doxyl sulfate; CMPF, 3-carboxy-4-methyl-5-propyl-2-furanpropionate;
IA, indoleacetate; HA, hippurate; PAH, p-aminohippurate; PCG,
benzylpenicillin.
Table 2. Ki values of uremic toxins uptake by rOat1- and
rOat3-expressing LLC-PK1 cells
PAH uptake PCG uptake
Inhibitor Ki for rOat1-LLC-PK1 Ki for rOat3-LLC-PK1
IS 25.0 ± 6.4 138 ± 38
CMPF 103 ± 21 27.9 ± 9.3
IA 48.5 ± 10.8 582 ± 113
HA 27.5 ± 4.3 18.6 ± 10.7
For abbreviations, see Table 1. The Ki values were determined by nonlinear
regression analysis. Data are taken from Figure 3. Units of Ki values are lmolL.
Each value represents the mean ± SD (N = 3).
Estimation of uptake clearance in kidney slices
from cDNA-transfected cells
The contributions of rOat1 and rOat3 to the renal up-
take of IS and CMPF were estimated based on the RAF
concept [16, 28]. The transport activities of IS and CMPF
by rOat1 and rOat3 were corrected by scaling factors for
rOat1 and rOat3 (RrOat1 and RrOat3, respectively). Com-
parison of the corrected transport activity by rOat1 and
rOat3 suggested that the contribution of rOat1 and rOat3
to the uptake of IS was 38% and 62%, respectively, and
that the corresponding values for CMPF uptake were
25% and 75%, respectively (Table 3).
The uptake clearances of uremic toxins by kidney slices
were predicted using the transport activities by cDNA-
transfected cells and scaling factors for rOat1 and rOat3
(Table 3). The absolute values for IA and HA uptake
were comparable between the predicted and observed
values, whereas the predicted values of IS and CMPF
were greater than the observed values (Table 3).
Effect of inhibitors on the uptake of uremic toxins
by rOat1-, rOat3-expressing LLC-PK1 cells,
and kidney slices
Figure 5 shows the inhibitory effect of PAH and PCG
on the uptake of uremic toxins by rOat1- and rOat3-
expressing LLC-PK1 cells. The Ki values of PAH for
rOat1- and rOat3-mediated transport were found to be
about 50 lmol/L and 1 mmol/L, respectively (Table 4).
The Ki values of PCG for rOat1- and rOat3-mediated
transport were about 2 mmol/L and 100 lmol/L, respec-
tively. These values agreed with previous reports [14, 29],
suggesting that PAH and PCG are selective inhibitors of
rOat1 and rOat3. However, PCG inhibited the uptake of
IA by rOat1 at a smaller Ki value compared with those for
the uptake of other uremic toxins by rOat1. The contribu-
tion of rOat1 and rOat3 will be evaluated by examining
their inhibitory effect of the uptake of uremic toxins by
kidney slices. The inhibitory effects of these inhibitors
on the uptake of uremic toxins by kidney slices were ex-
amined (Fig. 6), and their Ki values were summarized
in Table 4. DBSP, a nonspecific inhibitor for organic an-
ion transporters, markedly inhibited the uptake of uremic
toxins by kidney slices with Ki values similar to those for
PAH and pravastatin uptake by kidney slices (Fig. 6) [14].
The degree of inhibition by 300 lmol/L PAH, 100 lmol/L
pravastatin, and 300 lmol/L PCG, which selectively in-
hibit either rOat1 or rOat3, on the uptake of IS was ap-
proximately 45%, 60%, and 65%, respectively. The cor-
responding values were found to be approximately 30%,
70%, and 75%, respectively, for the uptake of CMPF, and
70%, 5%, and 10%, respectively, for the uptake of HA.
The inhibitory effect of 300 lmol/L PAH on the uptake
of IA was about 80%.
Uptake of uremic toxins by hOAT1- and
hOAT3-expressing HEK293 cells
The time profiles of the uptake of IS, CMPF, IA,
and HA by hOAT1- and hOAT3-expressing and vector-
transfected HEK293 cells are shown in Figure 7. The in-
tracellular accumulation of IS, CMPF, IA, and HA was
significantly greater in hOAT1-expressing cells than in
vector-transfected cells. On the other hand, a significant
increase in the uptake of IS and CMPF was observed in
hOAT3-expressing HEK293 cells, but not in the case of
IA and HA. The Km and Vmax values were determined
by kinetic analysis (Fig. 8). As shown in Table 5, the
kinetic parameters for hOATs-expressing transfectants
were very similar to those obtained for rOats-expressing
cells (Table 1). The inhibitory effect of uremic toxins on
the uptake via hOAT1 and hOAT3 is shown in Figure 9.
The Ki values obtained assuming competitive inhibition
are summarized in Table 6. These values also agreed with
those obtained for rOats-expressing cells as shown in
Table 2.
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Fig. 4. Time profiles and Eadie-Hofstee plots of the uptake of uremic toxins by kidney slices. The uptake of (A) 1 lmol/L [3H]IS, (B) 1 lmol/L
[3H]CMPF, (C) 1 lmol/L [3H]IA, and (D) 1 lmol/L [14C]HA by kidney slices was examined at 37◦C. The concentration dependence of (E) [3H]IS,
(F) [3H]CMPF, (G) [3H]IA, and (H) [14C]HA are shown as Eadie-Hofstee plots. The uptake by kidney slices was measured at concentrations
between 1 lmol/L and 10 mmol/L IS, and between 1 lmol/L and 1 mmol/L other toxins for 15 minutes at 37◦C. Adherent water was determined
by the uptake of mannitol, and that was subtracted from the distribution volume of uremic toxins. Each point represents the mean ± SE (N = 3).
Abbreviations are: IS, indoxyl sulfate; CMPF, 3-carboxy-4-methyl-5-propyl-2-furanpropionate; IA, indoleacetate; HA, hippurate.
Table 3. Comparison of uptake clearance in kidney slices with predicted values from the uptake study using rOat1- and
rOat3-expressing LLC-PK1 cells
rOat1-mediated uptake rOat3-mediated uptake Predicted value Observed value
mL/min/g of kidney
IS 0.271 (38%) 0.438 (62%) 0.709 0.161
CMPF 0.149 (25%) 0.443 (75%) 0.592 0.241
IA 0.113 – 0.113 0.195
HA 0.260 – 0.260 0.272
For abbreviations, see Table 1. The intrinsic transport activities of uremic toxins in cDNA-transfected cells (Vmax/Km) were obtained from
Table 1. The observed values represent the intrinsic transport activity by kidney slices. The intrinsic clearance of the component whose Km
value is comparable with that of the uptake in cDNA-transfected cells was used for the uptake of IS and CMPF. The contribution of rOat1- and
rOat3-mediated transport was given in parentheses. The RrOat1 and RrOat3 were 13.8 × 10−3 and 72.7 × 10−3, respectively. The details of the
calculation were described in Methods.
DISCUSSION
In the present study, we investigated the renal uptake
mechanism of uremic toxins, focusing on the contribution
of rOat1 and rOat3. The contribution of each transporter
was evaluated by saturation kinetics, RAF analysis, and
by examining the effect of inhibitors relatively selective
for rOat1 and rOat3.
rOat1-expressing LLC-PK1 cells exhibited marked ac-
cumulation of IS, CMPF, IA, and HA, while rOat3-
expressing LLC-PK1 cells exhibited significant uptake
of only IS and CMPF. IS had a 10-fold greater Km
value for rOat3 than rOat1, and the transport activity
of IS was greater in rOat1-expressing cells than in rOat3-
expressing cells. Conversely, CMPF had a 15-fold greater
Km value for rOat1 than rOat3, but the transport activ-
ities of rOat1 and rOat3 were similar (Fig. 2, Table 1).
Kinetic analysis of IS uptake by kidney slices revealed
two saturable and one nonsaturable components (Fig. 4),
and the Km values of IS for the high- and low-affinity
components were comparable with those of rOat1 and
rOat3, respectively. In the uptake of other uremic tox-
ins by kidney slices, one saturable and one nonsaturable
component was observed. The Km value of CMPF for
the uptake by kidney slices was comparable with that of
rOat3, while the Km values of IA and HA for the uptake
by kidney slices agreed with those of rOat1. These results
suggest that both rOat1 and rOat3 are involved in the re-
nal uptake of IS as high- and low-affinity sites, and rOat1
and rOat3 are involved in the renal uptake of IA and HA,
and CMPF, respectively.
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Fig. 5. Inhibitory effect of PAH and PCG
on the uptake of uremic toxins by rOat1-
and rOat3-expressing LLC-PK1 cells. rOat1-
mediated (A) 1lmol/L [3H]IS, (B) 1 lmol/L
[3H]CMPF, (C) 1 lmol/L [3H]IA, and (D)
2 lmol/L [14C]HA uptake for 1 minute were
determined in the presence and absence of
unlabeled PAH () and PCG (©) at the des-
ignated concentrations. (E) rOat3-mediated 1
lmol/L [3H]IS and (F) 1 lmol/L [3H]CMPF
uptake for 2 minutes were determined in the
presence and absence of unlabeled PAH ()
and PCG (•). The values are expressed as a
percentage of the uptake in the absence of
any unlabeled compounds. Solid lines repre-
sent the fitted line obtained by nonlinear re-
gression analysis. Each point represents the
mean ± SE (N = 3). Abbreviations are:
rOat, rat organic anion transporter; LLC-
PK1, pig kidney epithelial cell line; IS, indoxyl
sulfate; CMPF, 3-carboxy-4-methyl-5-propyl-
2-furanpropionate; IA, indoleacetate; HA,
hippurate; PAH, p-aminohippurate; PCG,
benzylpenicillin.
The contribution of rOat1 and rOat3 was quantified
in stable transformants by comparing their transport
activities corrected by the corresponding RAF values
(Table 3). The predicted contribution of rOat1 and rOat3
to the uptake of IS by kidney slices was approximately
40% and 60%, respectively. These values were compara-
ble with those of the high- and low-affinity component for
IS uptake by kidney slices. The corresponding values for
CMPF were approximately 25% and 75%, respectively
(Table 3). This was consistent with the observation that
the saturable component accounting for the majority of
CMPF uptake by kidney slices showed a Km value com-
parable with that for rOat3. The predicted and observed
uptake clearance of IA and HA were in good agreement,
whereas the predicted clearances of IS and CMPF were
several-fold greater than the observed values in kidney
slices (Table 3). The RAF method may not be applicable
to all substrates, and further studies are needed to de-
scribe the limitations of the RAF method in predicting in
vivo clearance from cDNA-transfected cells.
Furthermore, the contribution of rOat1 and rOat3 to
the total renal uptake of uremic toxins by kidney slices
was evaluated by examining the effect of relatively selec-
tive inhibitors of rOat1 and rOat3 (Fig. 6). PAH, pravas-
tatin, and PCG have been shown to exhibit a great dif-
ference in their Km or Ki values for rOat1 and rOat3
[14, 29]. In a recent study, the Ki value of PAH for the
uptake by rOat3 was calculated to be about 1 mmol/L,
which was 20-fold greater than the Ki value for the rOat1-
mediated uptake (Ki = about 50 lmol/L). PCG exhibited
a much higher affinity for rOat3 (Km = about 100 lmol/
L) than for rOat1 (Ki = about 2 mmol/L) (Fig. 5,
Table 4). These observations agree with previous reports
[14, 29]. In addition, pravastatin has been reported to ex-
hibit a much higher affinity for rOat3 (Km = 13 lmol/L)
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Fig. 6. Inhibitory effect of PAH, pravastatin, and DBSP on the uptake
of uremic toxins by kidney slices. The uptake of (A) 1 lmol/L [3H]IS, (B)
1 lmol/L [3H]CMPF, (C) 1 lmol/L [3H]IA, and (D) 1 lmol/L [14C]HA
for 15 minutes by kidney slices was determined in the presence and
absence of unlabeled PAH (), pravastatin (©), PCG (•), and DBSP
() at the designated concentrations. The values are expressed as a per-
centage of the uptake in the absence of any unlabeled compounds. Solid
lines represent the fitted line obtained by nonlinear regression analysis.
Each point represents the mean ± SE (N = 3). Abbreviations are: IS, in-
doxyl sulfate; CMPF, 3-carboxy-4-methyl-5-propyl-2-furanpropionate;
IA, indoleacetate; HA, hippurate; PAH, p-aminohippurate; PCG, ben-
zylpenicillin; DBSP, dibromosulfophthalein.
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Table 4. Ki values for the uptake of uremic toxins by rOat1-, rOat3-expressing LLC-PK1 cells, and kidney slices
IS uptake CMPF uptake IA uptake HA uptake
rOat1-LLC- rOat3-LLC- Kidney rOat1-LLC- rOat3-LLC- Kidney rOat1-LLC- Kidney rOat1-LLC- Kidney
Inhibitor PK1 PK1 slice PK1 PK1 slice PK1 slice PK1 slice
PAH 42.4 ± 6.7 1283 ± 333 – 75.2 ± 21.5 808 ± 204 781 ± 154 35.6 ± 9.5 20.5 ± 7.6 54.0 ± 9.9 100 ± 27
PCG 1890 ± 547 96.8 ± 30.9 – 2763 ± 978 132 ± 38 73.4 ± 21.1 470 ± 134 354 ± 46 2785 ± 1386 2082 ± 698
Pravastatin – – – – – 37.9 ± 13.8 – 315 ± 76 – 1966 ± 537
DBSP – – 21.6 ± 9.4 – – 23.9 ± 6.7 – 20.4 ± 6.8 – 21.7 ± 10.1
For abbreviations, See Table 1. The effects of PAH, PCG, pravastatin, and DBSP were examined on the uptake of uremic toxins by cDNA-transfected cells and
kidney slices. The Ki values were determined by nonlinear regression analysis. Reliable Ki values of the inhibitors for the uptake of IS by kidney slices were not
obtained. Data are taken from Figures 5 and 6. Units of Ki values are lmol/L. Each value represents the mean ± SD (N = 3).
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Fig. 7. Time profiles of the uptake of ure-
mic toxins by hOAT1- and hOAT3-expressing
HEK293 cells. The uptake of (A) 1 lmol/L
[3H]IS, (B) 1 lmol/L [3H]CMPF, (C) 1
lmol/L [3H]IA, and (D) 1 lmol/L [14C]HA
by cDNA-transfected cells was examined
at 37◦C. Squares, closed circles, and trian-
gles (), vector for hOAT1; , vector for
hOAT3 represents the uptake by hOAT1-
and hOAT3-expressing cells and vector-
transfected HEK293 cells, respectively. Each
point represents the mean ± SE (N =
3). Abbreviations are: IS, indoxyl sul-
fate; CMPF, 3-carboxy-4-methyl-5-propyl-2-
furanpropionate; IA, indoleacetate; HA,
hippurate; hOAT, human organic anion
transporter.
than for rOat1 (Ki = 1.2 mmol/L) [14]. Taking into con-
sideration the kinetic parameters of these inhibitors, 300
lmol/L PAH will saturate rOat1-mediated transport, but
will have only a minimal effect on the rOat3-mediated
uptake at this concentration. Therefore, the degree of in-
hibition for saturable uptake by kidney slices by PAH at
300 lmol/L represents the contribution of rOat1 to the
renal uptake of uremic toxins (IS, 45%; CMPF, 30%; IA,
80%; HA, 70% inhibition of the total saturable compo-
nent). Moreover, the Ki values of PAH for the uptake
of IA and HA by kidney slices were comparable with
those for rOat1 (Table 4). As for rOat3, the inhibitory
effects of 100 lmol/L pravastatin (IS, 60%; CMPF, 70%;
HA, 5% inhibition of the total saturable component) and
300 lmol/L PCG (IS, 65%; CMPF, 75%; HA, 10% inhi-
bition of the total saturable component) represents its
contribution. Inhibitory effect of PAH and PCG showed
different potency for the uptake of IA and HA by rOat1-
expressing cells. Their Ki values for IA uptake by rOat1
were 5- and 6-fold smaller than those for HA (Table 4).
This effect was also observed in kidney slices, in which
the Ki values of PAH and PCG for the uptake of IA were
smaller than those for HA, but comparable with those
for rOat1-mediated uptake of IA. A similar phenomenon
was also observed in the inhibitory effect of pravastatin,
whose Ki value for the uptake of IA by kidney slices was
markedly smaller than that of HA (Table 4). The contri-
bution of rOat1 and rOat3 to the renal uptake of uremic
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Fig. 8. Eadie-Hofstee plots of the uptake of uremic toxins PAH and PCG by hOAT1- and hOAT3-expressing HEK293 cells. The concentration
dependence of (A and F) [3H]IS, (B and G) [3H]CMPF, (C) [3H]IA, (D) [14C]HA, (E) [3H]PAH, and (H) [3H]PCG by cDNA-transfected cells is
shown. The uptake by hOAT1-expressing cells (A-E) was measured for 1 minute (uremic toxins) and 2 minutes (PAH) at various concentrations (IS,
CMPF, IA, and PAH, 0.3–1000 lmol/L, HA, 2–1000 lmol/L). The uptake by hOAT3-expressing cells (F-H) was measured for 3 minutes at various
concentrations (0.3–1000 lmol/L). The hOAT1- and hOAT3-mediated transports were obtained by subtracting the transport velocity in vector-
transfected cells from those in hOAT1- and hOAT3-expressing cells. Each point represents the mean ± SE (N = 3). Abbreviations are: IS, indoxyl
sulfate; CMPF, 3-carboxy-2-methyl-5-propyl-2-furanpropionate; IA, indoleacetate; HA, hippurate; PAH, p-aminohippurate; PCG, benzylpenicillin;
hOAT, human organic anion transporter
Table 5. Kinetic parameters of the uptake of uremic toxins PAH and PCG by hOAT1- and hOAT3-expressing HEK293 cells
hOAT1-HEK293 hOAT3-HEK293
Km Vmax Vmax/Km Km Vmax Vmax/Km
lmol/L pmol/min/mg of protein lL/min/mg of protein lmol/L pmol/min/mg of protein lL/min/mg of protein
IS 20.5 ± 5.3 216 ± 45 10.5 263 ± 40 505 ± 63 1.92
(0.573 ± 0.127)
CMPF 141 ± 10 801 ± 45 5.67 26.5 ± 3.0 76.5 ± 5.7 2.89
IA 14.0 ± 8.1 110 ± 50 7.86 – – –
(0.897 ± 0.224)
HA 23.5 ± 1.7 430 ± 19 18.3 – – –
PAH 20.1 ± 1.4 308 ± 18 15.4 – – –
(0.670 ± 0.048)
PCG – – – 54.0 ± 4.9 198 ± 13 3.67
For abbreviations, see Table 1. Data shown in Figure 8 were used to determine the kinetic parameters for the uptake of uremic toxins by cDNA-transfected cells. CLnon
values are given in parentheses. These parameters were determined by nonlinear regression analysis. Reproducibility of the transport activities by cDNA-transfected
cells (Vmax/Km) was confirmed by 3-7 individual experiments. In every experiment, PAH and PCG were used as reference compounds to check the transport activity
by cDNA-transfected cells and kidney slices. Each value represents the mean ± SD (N = 3).
toxins determined by the three different methods was in
a good agreement; rOat1 and rOat3 equally contribute to
the renal uptake of IS. rOat1 mainly accounts for IA and
HA uptake, whereas rOat3 accounts for CMPF uptake.
Previously, in an in vivo study using the KUI technique, it
was proposed that rOat3 mainly contributes to the renal
uptake of IS, in which the renal uptake of IS was signifi-
cantly inhibited by PAH and PCG [22]. Taking the present
results into consideration, inhibition by PAH and PCG in
an in vivo study supports the involvement of both rOat1
and rOat3 in the renal uptake of IS. In the previous study,
lack of inhibition by indomethacin was interpreted as a
minor contribution of rOat1 [22]. However, because in-
domethacin is highly associated with plasma protein, its
insufficient blood concentration after intra-arterial injec-
tion may account for this discrepancy.
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Fig. 9. Inhibitory effect of uremic toxins
on the uptake of [3H]PAH and [3H]PCG
by hOAT1- and hOAT3-expressing HEK293
cells. The uptake of (A) [3H]PAH and (B)
[3H]PCG by hOAT1 and hOAT3 was deter-
mined in the presence and absence of unla-
beled IS (), CMPF (©), IA (), HA (),
PAH (), and PCG (•) at the designated con-
centrations. The values are expressed as a per-
centage of the uptake in the absence of any un-
labeled compounds. Solid lines represent the
fitted line obtained by nonlinear regression
analysis. Each point represents the mean ± SE
(N = 3). Abbreviations are: IS, indoxyl sul-
fate; CMPF, 3-carboxy-4-methyl-5-propyl-2-
furanpropionate; IA, indoleacetate; HA, hip-
purate; PAH, p-aminohippurate; PCG, ben-
zylpenicillin; hOAT, human organic anion
transporter.
Table 6. Ki values of uremic toxins PAH and PCG uptake by hOAT1- and hOAT3-expressing HEK293 cells
Healthy volunteersa Predialysis patientsa
Ki for hOAT1 Ki for hOAT3 Total concentration Unbound concentration Total concentration Unbound concentration
Inhibitor lmol/L lmol/L lmol/L lmol/L lmol/L lmol/L
IS 13.2 ± 3.3 183 ± 44 4.10 0.16 104 12.9
CMPF 247 ± 63 27.9 ± 5.1 15.1 0.15b 183 1.83b
IA 21.0 ± 6.0 491 ± 57 1.45 0.44 26.3 3.92
HA 18.8 ± 4.7 30.8 ± 6.5 13.3 3.99b 271 122
PAH – 100 ± 13 – – – –
PCG 1703 ± 151 – – – – –
For abbreviations, see Table 1. The Ki values were determined by nonlinear regression analysis. Data are taken from Figure 9. Each value represents the mean ± SD
(N = 3)
a Sakai et al (1996)
b The unbound plasma concentrations were calculated from the total plasma concentrations and unbound fractions of CMPF (1%) and HA (30%), Niwa et al, 1996
The contribution of rOat3 to the uptake of IS and
CMPF by kidney slices was comparable to or greater than
that of rOat1, even though the transport activities of IS
and CMPF by rOat1 were greater or comparable with
those by rOat3. Taking into consideration the relatively
large difference in the scaling factors for rOat1 and rOat3,
this may be accounted for by the difference in their pro-
tein expression in the kidney, and/or the maintenance of
their driving force in the host cells. Further studies, es-
pecially quantification of the protein expression of rOat1
and rOat3 in the kidney, are needed to overcome this
discrepancy.
The human isoforms of rOat1 and rOat3, hOAT1 and
hOAT3, are predominantly expressed in the kidney and
localized on the basolateral membrane of the proximal
tubules [17–19]. hOAT1 exhibited significant uptake of
IS, CMPF, IA, and HA, while hOAT3 exhibited uptake
of IS and CMPF (Fig. 7). Furthermore, the Km and Ki
values for the uptake of uremic toxins by hOAT1 and
hOAT3 were almost comparable with those for the up-
take by rOat1 and rOat3. Thus, there was a minimal
species difference, at least in the Km values of uremic
toxins, between rats and humans. Using PAH as a refer-
ence substrate, the relative transport activities of hOAT1
for the uptake of uremic toxins (IS, 0.68; CMPF, 0.37;
IA, 0.51; HA, 1.19) were very similar to those of rOat1
(IS, 0.98; CMPF, 0.54; IA, 0.41; HA, 0.94) (Tables 1 and
5). However, the relative transport activities of IS and
CMPF were lower in hOAT3 (IS, 0.52; CMPF, 0.79) than
in rOat3 (IS, 2.19; CMPF, 2.21). The unbound concen-
tration of uremic toxins in normal serum is lower than
the Km values for hOAT1 and hOAT3 (IS, 0.16 lmol/L;
CMPF, 0.15 lmol/L; IA, 0.44 lmol/L; HA, 3.99 lmol/L)
[4, 30], and thus, the uptake by OATs should occur under
linear conditions. Assuming that the scaling parameters
are similar in rat and human, it is possible that the contri-
bution of hOAT3 to the renal uptake of IS and CMPF in
humans is smaller than in rat. This should be examined
in future studies, possibly using freshly prepared human
kidney slices.
Residual nephrons make a significant contribution to
the removal of uremic waste products in patients on
chronic dialysis treatment [31]. IS, CMPF, IA, and HA ac-
cumulate in uremic serum up to levels of 417, 370, 101, and
883 lmol/L, respectively [30, 32], and these compounds
depresses PAH transport by the kidney [20, 21]. The
present study proposes that hOAT1 and hOAT3 are po-
tential sites of interaction between uremic toxins and en-
dogenous or exogenous compounds. The unbound serum
concentrations of uremic toxins are listed in Table 6 [4,
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30], and the unbound serum concentrations of IS and HA
in predialysis patients were comparable with the Km and
Ki values for hOAT1 and hOAT3. Therefore, it is possi-
ble that IS and HA inhibit hOAT1- or hOAT3-mediated
transport in vivo in predialysis patients, leading to
acceleration of serum accumulation of uremic toxins, and
reduction of the plasma elimination of drugs via hOAT1
and hOAT3.
It has been demonstrated that active tubular secretion
is involved in the urinary excretion of IS, CMPF, IA, and
HA in rats, because their renal clearances were greater
than the glomerular filtration rate [2]. Also, the renal
clearance of IS and HA has been reported to be 29 and
590 mL/min in healthy people [33, 34]. Considering the
serum protein binding of IS (90–96%) and HA (70%) [4,
30], renal elimination of IS and HA into urine is mediated
by tubular secretion. To achieve the vectorial transport of
organic anions, it is likely that transporter(s) are involved
in the secretion across the brush border membrane of
the proximal tubules. It has been demonstrated that the
renal brush border membrane possesses an influx/efflux
transport system for organic anions, such as organic an-
ion transporting polypeptide 1 (Oatp1; Slc21a1), Oat-K1
(Slc21a4), Oat-K2, multidrug resistance associated pro-
tein 2 (Mrp2; Abcc2), Mrp4 (Abcc4), sodium phosphate
co-transporter 1 (Npt1; Slc17a1) in rodents, and MRP2
(ABCC2), MRP4 (ABCC4), NPT1 (SLC17A1), hOAT4
(SLC22A11), and URAT1 (SLC22A12) in humans [9, 35,
36]. In addition to the ABC transporter, hOAT4 has been
shown to mediate bidirectional transport of IS, suggest-
ing that hOAT4 is partly involved in the apical efflux of
IS in human proximal tubules [25]. These transporters
are candidate transporters involved in secretion and/or
reabsorption of uremic toxins. Further studies are neces-
sary to identify transporters responsible for the luminal
secretion of uremic toxins, and to investigate the interac-
tion between uremic toxins and endogenous/exogenous
organic anions via these transporters.
In patients of renal failure, pathophysiologic alter-
ations may affect the activity of transporters. It has been
suggested that the expression levels of some transporters
are changed in a rat model of renal failure [23, 37, 38].
rOat1, hOAT1, and rOAT3 are considered to be organic
anion/dicarboxylate exchangers indirectly coupled with
a Na+-dicarboxylate cotransporter [7, 17, 39], thus, ab-
normalities in energy metabolism may also influence the
transport activity in renal failure patients. Taking into
consideration the fact that accumulation of uremic tox-
ins, especially HA, attenuates the renal elimination via
rOats/hOATs, plasma HA may serve as a criterion to
evaluate the interaction of uremic toxins and drugs in
patients suffering from uremic syndrome. In addition, a
certain amount of uremic toxins is associated with plasma
and urine specimens from healthy subjects [30], which
enable us to obtain in vivo renal clearance and scaling
factors to extrapolate in vitro clearance to in vivo. Based
on the RAF concept, uremic toxins, especially HA, IA,
and CMPF, may be used as reference compounds to es-
timate roughly the renal clearance of organic anions and
therefore, to avoid excessive accumulation of drugs in the
body prior to treatment. Further clinical studies are nec-
essary to validate the correlation between renal clearance
of uremic toxins and drugs.
CONCLUSION
We have demonstrated that rOat1/hOAT1 and
rOat3/hOAT3 are responsible for the renal uptake of ure-
mic toxins on the basolateral membrane of the proximal
tubules. Both rOat1 and rOat3 contribute to IS trans-
port in the kidney. rOat1 is predominantly responsible
for the renal uptake of IA and HA, while rOat3 plays a
major role in the renal uptake of CMPF. Furthermore,
rOat1/hOAT1 and rOat3/hOAT3 are potential sites of
interaction between uremic toxins and endogenous or
exogenous compounds. These findings may help us un-
derstand the pathophysiologic functions of the kidney as
a detoxifying system and improve the treatment of uremic
patients.
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